Thursday, 5 November, 2026

Morning Sessions 08:00-12:00 CET

08:00-08:20 Welcome

Frank Lammert, Francisco Hernández, Piotr Kaliciński, Ulrich Baumann

08:20-08:40 Addressing Paediatric Transplantation as a Rare Disease: Challenges and Opportunities

George Mazariegos – UPMC Children’s Hospital of Pittsburgh (USA)

08:40-09:00 Experiences at the World Transplant Games and French National Games

Young athletes from France and Germany

09:00-09:20 Vaccination after Transplantation

Tobias Laue (Freiburg)

09:20-09:40 PTLD Management after Transplantation

Britta Maecker-Kolhoff (Hannover)

09:40-10:10 COFFEE BREAK

10:10-10:30 Cardiovascular complications after Transplantation

Anette Melk (Hannover)

10:30-10:50 ECMO for the Critically Ill Child after Solid Organ Transplantation

Harald Köditz (Hannover)

10:50-11:10 Expanding the Clinical Spectrum of Mitochondriopathies: Deoxyguanosine Kinase Deficiency as a Key Driver of Fibrotic Lung Disease

Sandra von Hardenberg (Hannover)

Nicolaus Schwerk (Hannover)

11:10-11:30 The orgamites Mighty Method: Three pillars to teaching foundational health education that’s inclusive of Organ Donation

Roydon Turner (London)

11:30-12:00 Novel strategies for Immunosuppression in Solid Organ Recipients

Panel Discussion

12:00-14:00 LUNCH BREAK

12:45-13:45 Industry Symposium

Afternoon Sessions 14:00-18:00 CET

14:00-14:20 Food allergies after Solid Organ Transplantation in paediatric patients

Guiseppe Indolfi (Florence)

Francesca Mori (Florence)

14:20-14:40 Changing Landscape of Indications for Lung Transplantation

Nicolaus Schwerk (Hannover)

14:40-15:00 Acute and Chronic Renal Dysfunction after Solid Organ Transplantation

Nele Kanzelmeyer (Hannover)

15:00-15:20 Endothelial Injury and TA-TMA in Paediatric Transplantation

Rita Beier (Hannover)

15:20-15:40 Obesity and MASLD after Transplantation in Childhood

Emer Fitzpatrick (Dublin)

15:40-16:00 COFFEE BREAK

16:00-16:20 PH1 and MMA – Is a Combined Transplant Advisable?

Jun Oh (Hamburg)

16:20-16:40 Cellular Therapies in Solid Organ Transplantation

Julien Zuber (Paris)

16:40 – 17:00 Cell-Free DNA in Paediatric Solid Organ Transplantation

Evgenia Preka (Paris)

17:00-17:20 Opportunities and Risks of Ex Vivo Perfusion Systems in Solid Organ Transplantation in Childhood

Francisco Hernández (Madrid)

17:20-17:40 Fontan and Fontan-Associated Liver Disease: Combined Heart–Liver Transplantation

Juliet Emamaullee (USA)

17:40-18:00 Haematological problems after Solid Organ Transplantation

Martin Castelle (Paris)

*Be aware that the programme may be subject to modification